Francesco Patti

19.6k total citations · 3 hit papers
332 papers, 9.7k citations indexed

About

Francesco Patti is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Francesco Patti has authored 332 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 244 papers in Pathology and Forensic Medicine, 93 papers in Neurology and 59 papers in Oncology. Recurrent topics in Francesco Patti's work include Multiple Sclerosis Research Studies (239 papers), Peripheral Neuropathies and Disorders (57 papers) and Polyomavirus and related diseases (48 papers). Francesco Patti is often cited by papers focused on Multiple Sclerosis Research Studies (239 papers), Peripheral Neuropathies and Disorders (57 papers) and Polyomavirus and related diseases (48 papers). Francesco Patti collaborates with scholars based in Italy, United States and United Kingdom. Francesco Patti's co-authors include María Trojano, Maria Pia Amato, Emanuele D’Amico, A. Reggio, Mario Zappia, Salvatore Lo Fermo, Benedetta Goretti, Carmela Leone, Alessandra Nicoletti and Angelo Ghezzi and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Francesco Patti

321 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

2019 415 citations Takashi Yamamura, Ingo Kleiter et al. profile →
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

2021 296 citations Gioacchino Tedeschi, Mario Alberto Battaglia et al. profile →
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

2022 104 citations Diego Centonze, Paolo Gallo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco Patti Italy	49	6.3k	2.8k	1.2k	1.1k	1.1k	332	9.7k
Anat Achiron Israel	51	4.3k 0.7×	2.0k 0.7×	1.2k 1.0×	850 0.7×	687 0.6×	320	8.6k
Timothy Vollmer United States	47	5.4k 0.8×	1.8k 0.6×	776 0.6×	1.0k 0.9×	917 0.9×	125	8.0k
Angelo Ghezzi Italy	52	8.2k 1.3×	3.6k 1.3×	591 0.5×	2.0k 1.7×	1.1k 1.0×	219	10.1k
Bruno Brochet France	50	5.4k 0.9×	2.4k 0.8×	903 0.8×	1.1k 1.0×	743 0.7×	180	9.4k
Christoph Heesen Germany	51	5.0k 0.8×	1.5k 0.5×	1.4k 1.2×	610 0.5×	614 0.6×	275	8.6k
Maria Pia Amato Italy	57	11.8k 1.9×	4.1k 1.5×	1.3k 1.1×	2.2k 1.9×	1.2k 1.1×	274	14.0k
Steven Galetta United States	60	5.5k 0.9×	6.4k 2.3×	926 0.8×	1.7k 1.5×	1.4k 1.3×	451	14.1k
John D. Fisk Canada	63	5.9k 0.9×	2.1k 0.8×	3.2k 2.7×	1.9k 1.7×	563 0.5×	246	12.9k
Helmut Butzkueven Australia	42	4.3k 0.7×	1.6k 0.6×	648 0.5×	812 0.7×	943 0.9×	295	7.2k
Donald E. Goodkin United States	41	8.7k 1.4×	3.1k 1.1×	1.1k 0.9×	2.2k 2.0×	1.6k 1.5×	80	11.0k

Countries citing papers authored by Francesco Patti

Since Specialization

Citations

This map shows the geographic impact of Francesco Patti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Patti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Patti more than expected).

Fields of papers citing papers by Francesco Patti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Patti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Patti. The network helps show where Francesco Patti may publish in the future.

Co-authorship network of co-authors of Francesco Patti

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Patti. A scholar is included among the top collaborators of Francesco Patti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Patti. Francesco Patti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bennett, Jeffrey L., Kazuo Fujihara, Albert Saiz, et al.. (2025). Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study. Neurology Neuroimmunology & Neuroinflammation. 12(6). e200494–e200494. 1 indexed citations

Chisari, Clara Grazia, Salvatore Lo Fermo, Salvatore Iacono, et al.. (2025). Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients. Neurotherapeutics. 22(6). e00724–e00724. 1 indexed citations

Butzkueven, Helmut, Tomáš Kalinčík, Francesco Patti, et al.. (2024). Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic Advances in Neurological Disorders. 17. 4223502419–4223502419. 2 indexed citations

Tacchino, Andrea, Michela Ponzio, Paolo Confalonieri, et al.. (2023). An Internet- and Kinect-Based Multiple Sclerosis Fitness Intervention Training With Pilates Exercises: Development and Usability Study. JMIR Serious Games. 11. e41371–e41371. 1 indexed citations

Solaro, Claudio, Giampaolo Brichetto, Andrea Tacchino, et al.. (2022). Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis. European Journal of Neurology. 30(1). 172–178. 8 indexed citations

Hartung, H-P, Thomas Berger, Bruno Brochet, et al.. (2020). Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102492–102492. 22 indexed citations

Cortesi, Paolo Angelo, et al.. (2020). PMS24 Multiple Sclerosis Disease Progression Simulation: The Importance of Specific DATA for Progressive and Relapsing Course. Value in Health. 23. S596–S597. 1 indexed citations

Chisari, Clara Grazia, Mario Damiano Toro, Vincenzo Cimino, et al.. (2019). Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients. Journal of Clinical Medicine. 8(11). 2022–2022. 19 indexed citations

D’Amico, Emanuele, Aurora Zanghì, Alessandra Romano, et al.. (2019). The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis. Cells. 8(10). 1114–1114. 48 indexed citations

10.

Nicoletti, Alessandra, Héctor H. Garcı́a, Calogero Edoardo Cicero, et al.. (2019). Lack of evidence for Toxocara infection in Italian myelitis patients. Neurological Sciences. 41(1). 239–241. 1 indexed citations

11.

Kleiter, Ingo, Jacqueline Palace, Benjamin Greenberg, et al.. (2018). A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as add-on therapy for neuromyelitis optica (NMO) and NMO spectrum disorder (NMOSD). European Journal of Neurology. 25. 536–536. 1 indexed citations

12.

Sèze, J. de, Ingo Kleiter, Jacqueline Palace, et al.. (2018). A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as add-on therapy for neuromyelitis optica spectrum disorder (NMOSD). Multiple Sclerosis Journal. 24. 985–986. 5 indexed citations

13.

Leone, Carmela, Peter Feys, Lousin Moumdjian, et al.. (2017). Cognitive-motor dual-task interference: A systematic review of neural correlates. Neuroscience & Biobehavioral Reviews. 75. 348–360. 226 indexed citations

14.

Rampello, Liborio, et al.. (2016). When the word doesn't come out: A synthetic overview of dysarthria. Journal of the Neurological Sciences. 369. 354–360. 20 indexed citations

15.

D’Amico, Emanuele, Carmela Leone, Cinzia Caserta, & Francesco Patti. (2015). Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal. Expert Review of Neurotherapeutics. 15(7). 803–824. 24 indexed citations

16.

Fragalà, Eugenia, Sebastiano Cimino, Giorgio Ivan Russo, et al.. (2014). Determinants of sexual impairment in multiple sclerosis male and female patients with lower urinary tract dysfunction: results from an Italian cross-sectional study.. Neurourology and Urodynamics. 1 indexed citations

17.

Lavorgna, Luigi, Simona Bonavita, Domenico Ippolito, et al.. (2013). Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. Multiple Sclerosis Journal. 20(2). 220–226. 30 indexed citations

18.

Patti, Francesco, Alessandra Nicoletti, Carmela Leone, et al.. (2012). Multiple Sclerosis and CCSVI: A Population-Based Case Control Study. PLoS ONE. 7(8). e41227–e41227. 23 indexed citations

19.

Patti, Francesco. (2001). Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 71(3). 404–407. 44 indexed citations

20.

Rampello, Liborio, Francesco Patti, D. F. Condorelli, et al.. (1982). Effects of some typical and atypical antidepressants on GAD activity in various brain regions.. IRIS Research product catalog (Sapienza University of Rome). 8(1). 89–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact